Re Remco, I’ve come to the conclusion that he’s a tremendously talented rider (he was the most talented of his generation from an early age) who is relatively clean in comparison to other elite level cyclists. Hence his lack of top climbing performance and the variability in his overall performance levels. He also appears to be vulnerable to illnesses and fatigue, something we can’t really see in the Slovenian boy wonder. And unlike him, Remco had no qualms about competing in the Olympic Games, which probably indicates he’s more than happy to give blood samples that can be retained for future testing. If Remco was cycling during the 2010s he’d have won at least a couple of TDFs as his climbing abilities would be good enough to be up there with the likes of Wiggins and Froome, and he could more than hold his own time trialling.
I used to think this way about Cadel Evans. But I didn't openly accuse Alberto Contador of being purely a creation of doping. Remco's climbing is too inconsistent. He was great in the 2022 Vuelta (actually only a single decisive climb) and in the 2024 Tour. And again, you are not the only person here but I am not sure why we think results as a junior always extrapolate to a professional career? It doesn't and I've checked that.
I think Remco would have been destroyed in the mountains by both Contador and Nibali at his 2013-2014 peak. I guess you are basing on his level in the 2024 TdF. A sample of 1. He is too inconsistent as you say, fell apart last year.
There are also a number of other riders in today's peloton not riding for UAE who I think are consistently better climbers than Remco whose names are not Pogacar. Not only Vingegaard.
As for Pogacar avoiding the Olympics due to the possibility of retrospective testing, interesting theory. But I think more pressure should be placed on the UCI / ITA to properly analyze the samples they get rather than rely on retrospective testing. Don't get mad, get active. But I am surprised the UCI isn't aligned with the IOC on retrospective testing.